Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6729
Rank
ยฃ0.49 B
Marketcap
ยฃ24.51
Share price
0.00%
Change (1 day)
-2.38%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total assets

Total assets on the balance sheet as of June 2025 : ยฃ0.11 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total assets are ยฃ0.11 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avalon Pharma (Middle East Pharmaceutical) - Total assets on balance sheet (from 2023 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ0.11 B17.92%
2023-12-31ยฃ94.88 M